We are live on ! Find out more
QSS

Quantitative Systematic Strategies Portfolio holdings

AUM $11.5M
1-Year Est. Return 21.96%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+21.96%
3 Year Est. Return
+132.64%
5 Year Est. Return
+157.08%
10 Year Est. Return
AUM
$366M
AUM Growth
+$117M
Cap. Flow
+$112M
Cap. Flow %
30.53%
Top 10 Hldgs %
12.29%
Holding
561
New
245
Increased
96
Reduced
67
Closed
153

Top Sells

Rank Stock Value
1
WPX
WPX Energy, Inc.
WPX
+$3.8M
2
AGN
Allergan Inc
AGN
+$3.44M
3
FDX icon
FedEx
FDX
+$3.22M
4
FMC icon
FMC
FMC
+$3.18M
5
TRN icon
Trinity Industries
TRN
+$3.06M

Sector Composition

Rank Sector Weight
1 Financials 12.99%
2 Healthcare 12.98%
3 Consumer Discretionary 12.04%
4 Industrials 11.12%
5 Energy 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLYP
251
DELISTED
RELYPSA INC COM
RLYP
$411K 0.11%
+11,423
New +$412K
CAVM
252
DELISTED
Cavium, Inc.
CAVM
$411K 0.11%
5,665
+1,204
+27% +$78.2K
DVN icon
253
Devon Energy
DVN
$52.2B
$410K 0.11%
6,747
-8,296
-55% -$506K
PAYX icon
254
Paychex
PAYX
$39.4B
$407K 0.11%
+8,135
New +$395K
FTD
255
DELISTED
FTD Companies, Inc. Common Stock
FTD
$406K 0.11%
+13,360
New +$446K
TWTR
256
DELISTED
Twitter, Inc.
TWTR
$403K 0.11%
+8,079
New +$358K
NSTG
257
DELISTED
NanoString Technologies, Inc.
NSTG
$402K 0.11%
+37,669
New +$462K
ABBV icon
258
AbbVie
ABBV
$454B
$400K 0.11%
+6,868
New +$415K
ALNY icon
259
Alnylam Pharmaceuticals
ALNY
$35.9B
$400K 0.11%
+3,711
New +$376K
AMT icon
260
American Tower
AMT
$76.7B
$400K 0.11%
+4,160
New +$404K
AVDL
261
DELISTED
Avadel Pharmaceuticals
AVDL
$400K 0.11%
+22,198
New +$348K
BBWI icon
262
Bath & Body Works
BBWI
$3.9B
$400K 0.11%
+5,252
New +$379K
CAKE icon
263
Cheesecake Factory
CAKE
$4.2B
$400K 0.11%
+8,086
New +$408K
CATY icon
264
Cathay General Bancorp
CATY
$4.19B
$400K 0.11%
+14,129
New +$364K
CCEP icon
265
Coca-Cola Europacific Partners
CCEP
$45.8B
$400K 0.11%
+8,947
New +$391K
HBAN icon
266
Huntington Bancshares
HBAN
$35.3B
$400K 0.11%
+36,331
New +$384K
HLF icon
267
Herbalife
HLF
$1.22B
$400K 0.11%
+18,726
New +$320K
HOMB icon
268
Home BancShares
HOMB
$6.16B
$400K 0.11%
+23,358
New +$370K
INGN icon
269
Inogen
INGN
$171M
$400K 0.11%
+12,251
New +$395K
KSS icon
270
Kohl's
KSS
$2.06B
$400K 0.11%
5,221
+257
+5% +$17.5K
LH icon
271
Labcorp
LH
$23.9B
$400K 0.11%
+3,658
New +$376K
MMSI icon
272
Merit Medical Systems
MMSI
$4.36B
$400K 0.11%
+20,779
New +$370K
MSFT icon
273
Microsoft
MSFT
$2.83T
$400K 0.11%
+9,766
New +$425K
OMC icon
274
Omnicom Group
OMC
$22.2B
$400K 0.11%
+5,126
New +$391K
PFG icon
275
Principal Financial Group
PFG
$23.2B
$400K 0.11%
+7,799
New +$392K

Similar funds

Quantitative Systematic Strategies's Q1 2015 Portfolio in Review

As of Q1 2015, Quantitative Systematic Strategies held 561 positions worth $366M, up 47% from $249M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Quantitative Systematic Strategies deployed $112M of net new capital in Q1 2015, opening 245 new positions and adding to 96 existing holdings. Its largest new stake was Eastman Chemical: 61,939 shares worth $4.34M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was FMC, an estimated $3.18M trimmed.

  • Quantitative Systematic Strategies's largest Q1 2015 buy was Eastman Chemical: 61,939 shares worth $4.34M.
  • Quantitative Systematic Strategies added most to Rowan Companies Plc in Q1 2015, an estimated $7M increase.
  • Quantitative Systematic Strategies's biggest Q1 2015 reduction was FMC, cutting an estimated $3.18M.
  • Quantitative Systematic Strategies fully exited WPX Energy, Inc. in Q1 2015, selling an estimated $3.8M.
  • Quantitative Systematic Strategies's ten largest holdings make up 12% of its $366M portfolio in Q1 2015.
  • Quantitative Systematic Strategies opened 245 new positions and closed 153 in Q1 2015.
  • Quantitative Systematic Strategies's portfolio value rose 47% quarter-over-quarter to $366M.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2015, filed 9 Apr 2015.